HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TRANSTHERA-B

10.310

-0.070-0.67%

Volume:4.54M

Turnover:46.60M

Market Cap:4.20B

PE:-11.63

High:10.440

Open:10.440

Low:10.120

Close:10.380

52wk High:679.500

52wk Low:9.010

Shares:407.00M

HK Float Shares:312.00M

Volume Ratio:0.52

T/O Rate:1.46%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.887

ROE:-62.88%

ROA:-32.06%

PB:8.64

PE(LYR):-11.63

PS:- -

Loading ...

Overview Company News Filings

TRANSTHERA-B Secures Regulatory Approval for Phase II Trial of TT-01488 Combination Therapy in Mantle Cell Lymphoma

TransThera Sciences gains NMPA nod for Phase II study of BTK inhibitor TT-01488 plus anti-CD20 antibody in mantle cell lymphoma

Bulletin Express

TransThera Sciences Completes Enrollment for Global Phase III Tinengotinib Trial in Advanced Cholangiocarcinoma

Bulletin Express

Transthera Completes Enrollment in Phase III Tinengotinib Trial for Advanced Cholangiocarcinoma

Transthera Says China Regulator Clears Phase II Trial of Tt-01488 Combo in Mantle Cell Lymphoma

Movement Alert｜TransThera Sciences-B Intraday Decline 8.18%, Buyback Plan Boost Fades as Post-Lockup Selling Pressure Persists

Movement Alert｜TransThera Sciences-B Rises 19.89% in Regular Trading, Company Announces Up to RMB 100 Million H-Share Buyback Plan

Transthera Sciences Jumps Most in Nearly Four Months on Share Buyback Plan

HK Movers | Hong Kong Biotech Sector Strengthened; TRANSTHERA Rose More Than 20%

Tiger Newspress

TRANSTHERA-B Announces Market Buyback Plan Under General Mandate

TransThera Sciences plans on-market buyback of up to RMB100.00 million under existing mandate

Bulletin Express

Innovative Drug Firm's Market Value Plummets Over 200 Billion in a Year, Top Executives Draw Millions in Pay Despite Zero Revenue

TRANSTHERA-B Shares Extend Losses, Hitting New Low with Market Cap Below HK$4.5 Billion

TRANSTHERA-B Shares Plunge Approximately 60% Amid Major Shareholder Lock-Up Expiry and Three Discounted Placements in Six Months

TransThera Sets Up Strategy Committee to Tighten Governance and Guide Long-Term Investments

TransThera Sciences: All AGM Resolutions Cleared; New INED Appointed, Supervisory Committee Dissolved

Bulletin Express

Transthera Sciences files directors list with Hong Kong Stock Exchange

Appointment of Feng Weibo as Independent Non-Executive Director at TRANSTHERA-B

TransThera Sciences names Feng Weibo independent director, replacing Zheng Zhelan

TRANSTHERA-B Appoints Sun Delong as Chief Operating Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02617/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"TRANSTHERA-B","latestPrice":10.31,"timestamp":1787299687057,"preClose":10.38,"halted":0,"volume":4543800,"delay":0,"changeRate":-0.006743737957610817,"floatShares":312000000,"shares":407000000,"eps":-0.8868345239122081,"marketStatus":"Market Closed","change":-0.07,"latestTime":"08-21 16:08:07","open":10.44,"high":10.44,"low":10.12,"amount":46601191,"amplitude":0.030829,"askPrice":10.31,"askSize":5000,"bidPrice":10.3,"bidSize":10500,"shortable":3,"etf":0,"ttmEps":-0.8863140920731754,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":10.38,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.5223118835745755,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":312000000,"roa":"-32.06%","roe":"-62.88%","lyrEps":-0.886835,"volumeRatio":0.5223118835745755,"shares":407000000,"dividePrice":0,"high":10.44,"amplitude":0.030829,"preClose":10.38,"low":10.12,"week52Low":9.01,"pbRate":"8.64","week52High":679.5,"institutionHeld":0,"latestPrice":10.31,"committee":0.354839,"eps":-0.8868345239122081,"divideRate":0,"volume":4543800,"delay":0,"ttmEps":-0.8863140920731754,"open":10.44,"prevYearClose":114.9,"prevWeekClose":10.33,"prevMonthClose":9.95,"prevQuarterClose":11.55,"fiveDayClose":10.33,"twentyDayClose":10.19,"sixtyDayClose":38.7,"earningDate":1787673600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"market":"HK","date":"2026-03-31","symbol":"02617","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774886400000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2026-08-21","current":-11.632445,"percent":0.95122,"low":-380.446233,"twenty":-208.418403,"median":-81.461274,"eighty":-38.522204,"high":-10.87103,"avg":-114.757849,"sd":96.187407,"marketCap":4205641106},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-24","current":-293.038662,"twenty":-206.454369,"median":-63.574223,"eighty":-42.029097,"marketCap":75807447903},{"date":"2025-10-31","current":-281.572204,"twenty":-212.338922,"median":-65.741367,"eighty":-42.067733,"marketCap":72949784945},{"date":"2025-11-07","current":-338.772318,"twenty":-240.199465,"median":-68.232426,"eighty":-42.195906,"marketCap":87714376893},{"date":"2025-11-14","current":-312.135011,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"marketCap":81046496658},{"date":"2025-11-21","current":-312.892206,"twenty":-281.392507,"median":-71.392356,"eighty":-43.133487,"marketCap":81205255711},{"date":"2025-11-28","current":-305.66478,"twenty":-292.6573,"median":-72.756691,"eighty":-44.126885,"marketCap":79617665179},{"date":"2025-12-05","current":-292.058382,"twenty":-294.387608,"median":-99.507708,"eighty":-45.187328,"marketCap":76204345536},{"date":"2025-12-12","current":-243.995471,"twenty":-293.167092,"median":-152.573856,"eighty":-47.193393,"marketCap":63781449623},{"date":"2025-12-19","current":-248.269013,"twenty":-292.997062,"median":-174.177612,"eighty":-49.176233,"marketCap":65051522048},{"date":"2025-12-24","current":-196.609225,"twenty":-292.87226,"median":-176.029803,"eighty":-49.50215,"marketCap":51676071816},{"date":"2026-01-02","current":-170.268162,"twenty":-292.367293,"median":-176.029803,"eighty":-50.024601,"marketCap":44928812055},{"date":"2026-01-09","current":-172.395935,"twenty":-291.502465,"median":-173.687618,"eighty":-50.606284,"marketCap":45603538031},{"date":"2026-01-16","current":-142.824051,"twenty":-290.689477,"median":-172.622298,"eighty":-50.90198,"marketCap":37903723951},{"date":"2026-01-23","current":-125.658859,"twenty":-289.035292,"median":-170.268162,"eighty":-51.777834,"marketCap":33316302355},{"date":"2026-01-30","current":-123.813683,"twenty":-286.862177,"median":-169.566856,"eighty":-52.840115,"marketCap":32977154367},{"date":"2026-02-06","current":-105.494623,"twenty":-283.350344,"median":-167.82666,"eighty":-53.700055,"marketCap":28169232889},{"date":"2026-02-13","current":-102.143547,"twenty":-281.033113,"median":-142.637109,"eighty":-54.549461,"marketCap":27431087268},{"date":"2026-02-20","current":-99.091969,"twenty":-280.673719,"median":-140.820404,"eighty":-54.88737,"marketCap":26573242357},{"date":"2026-02-27","current":-101.401985,"twenty":-277.873293,"median":-135.446139,"eighty":-55.077905,"marketCap":27490936913},{"date":"2026-03-06","current":-136.499284,"twenty":-268.489172,"median":-127.818396,"eighty":-56.170035,"marketCap":36707782236},{"date":"2026-03-13","current":-113.20329,"twenty":-265.946326,"median":-125.658859,"eighty":-56.966285,"marketCap":30583168569},{"date":"2026-03-20","current":-101.699451,"twenty":-264.885138,"median":-122.419285,"eighty":-57.460964,"marketCap":27371237623},{"date":"2026-03-27","current":-103.891016,"twenty":-259.5894,"median":-118.720319,"eighty":-57.713018,"marketCap":27889934546},{"date":"2026-04-02","current":-103.689961,"twenty":-256.279611,"median":-116.735022,"eighty":-57.836913,"marketCap":27969734073},{"date":"2026-04-10","current":-80.663784,"twenty":-255.242863,"median":-113.754326,"eighty":-57.879207,"marketCap":27371237623},{"date":"2026-04-17","current":-81.335146,"twenty":-254.749157,"median":-113.20329,"eighty":-57.943799,"marketCap":27610636203},{"date":"2026-04-24","current":-69.75013,"twenty":-253.791099,"median":-110.250158,"eighty":-58.025793,"marketCap":23679242293},{"date":"2026-04-30","current":-61.379887,"twenty":-252.626844,"median":-107.193308,"eighty":-58.709304,"marketCap":20850663862},{"date":"2026-05-08","current":-65.459145,"twenty":-251.564027,"median":-106.48355,"eighty":-58.020504,"marketCap":22305361341},{"date":"2026-05-15","current":-57.457667,"twenty":-249.188687,"median":-106.083059,"eighty":-57.919993,"marketCap":19630334311},{"date":"2026-05-22","current":-50.784784,"twenty":-247.674355,"median":-104.198267,"eighty":-57.649604,"marketCap":17310899997},{"date":"2026-05-29","current":-41.763424,"twenty":-245.295721,"median":-103.852131,"eighty":-57.457667,"marketCap":14285310527},{"date":"2026-06-05","current":-37.606441,"twenty":-243.995471,"median":-103.234551,"eighty":-55.321243,"marketCap":12882070430},{"date":"2026-06-12","current":-38.299212,"twenty":-239.592317,"median":-102.28828,"eighty":-53.347698,"marketCap":13110504864},{"date":"2026-06-18","current":-33.64261,"twenty":-235.649979,"median":-102.143547,"eighty":-51.161877,"marketCap":11544097313},{"date":"2026-06-26","current":-10.87103,"twenty":-223.802745,"median":-101.125662,"eighty":-50.162538,"marketCap":3712059560},{"date":"2026-07-03","current":-14.085963,"twenty":-220.323597,"median":-100.505297,"eighty":-47.51031,"marketCap":4813439869},{"date":"2026-07-10","current":-12.489761,"twenty":-217.694001,"median":-99.314488,"eighty":-43.652943,"marketCap":4262749714},{"date":"2026-07-17","current":-11.456979,"twenty":-215.893769,"median":-98.774546,"eighty":-42.55123,"marketCap":3924177249},{"date":"2026-07-24","current":-12.133097,"twenty":-213.808047,"median":-93.131819,"eighty":-41.957553,"marketCap":4156690870},{"date":"2026-07-31","current":-11.824868,"twenty":-212.088453,"median":-87.290837,"eighty":-41.541423,"marketCap":4058790398},{"date":"2026-08-07","current":-13.332054,"twenty":-210.416628,"median":-83.155604,"eighty":-40.356892,"marketCap":4585005434},{"date":"2026-08-14","current":-12.237188,"twenty":-208.788963,"median":-82.408413,"eighty":-39.630155,"marketCap":4213799478},{"date":"2026-08-21","current":-12.186563,"twenty":-208.418403,"median":-81.461274,"eighty":-38.522204,"marketCap":4205641106}],"updateTime":1787493137953},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1165007087","title":"TRANSTHERA-B Secures Regulatory Approval for Phase II Trial of TT-01488 Combination Therapy in Mantle Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1165007087","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165007087?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:38","pubTimestamp":1782905913,"startTime":"0","endTime":"0","summary":"The China National Medical Products Administration (NMPA) has granted approval for a Phase II clinical trial of TRANSTHERA-B's (ASX: 02617) product, TT-01488 tablets, in combination with an anti-CD20...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","BK1161","LU2279689827.SGD","IE0004086264.USD","LU1732799900.SGD","LU2764263203.CNY","LU2229751404.USD","LU0154245756.USD","LU2211817866.USD","SG9999002232.USD","LU0323239441.USD","LU0795875086.SGD","LU2347655073.USD","LU2764263039.SGD","LU1718418525.SGD","BK4504","LU2764262908.HKD","LU2552382215.SGD","BK4585","TT","BK4086","LU0070217475.USD","BK4533","LU2211814178.USD","01488","BK4588","LU2552382058.USD","IE00BGHQF417.EUR","LU2394011477.USD","LU0238689110.USD","LU2347655156.SGD","LU2552382132.HKD","LU0266013472.USD","SG9999002224.SGD","IE00B2PGVK34.USD","IE00B3CCJ633.GBP","LU2089279066.USD","LU0323240290.USD","LU2720916845.USD","LU1732800096.USD","IE0004091025.USD","02617","IE00BKVL7J92.USD","LU2133065610.SGD","LU2463526074.USD","BK1233","LU0154245673.USD","LU0210533765.USD","LU0795875169.SGD","LU0726765562.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154644853","title":"TransThera Sciences gains NMPA nod for Phase II study of BTK inhibitor TT-01488 plus anti-CD20 antibody in mantle cell lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1154644853","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154644853?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:25","pubTimestamp":1782905141,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Stock Name: TRANSTHERA-B) announced that China’s National Medical Products Administration granted approval on 1 July 2026 for a Phase II clinical trial evaluating TT-01488...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134347564","title":"TransThera Sciences Completes Enrollment for Global Phase III Tinengotinib Trial in Advanced Cholangiocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1134347564","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134347564?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:25","pubTimestamp":1782905102,"startTime":"0","endTime":"0","summary":"TransThera Sciences (TRANSTHERA-B, 02617) announced the completion of patient enrollment for its global, multicenter, registrational Phase III study evaluating Tinengotinib (TT-00420) monotherapy in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648179985","title":"Transthera Completes Enrollment in Phase III Tinengotinib Trial for Advanced Cholangiocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2648179985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648179985?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:11","pubTimestamp":1782904317,"startTime":"0","endTime":"0","summary":"TransThera completes enrollment in Phase III tinengotinib trial for advanced cholangiocarcinomaTransthera Sciences (Nanjing) completed enrollment in a global, registrational Phase III trial of tinengo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL7yf7Yr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648173425","title":"Transthera Says China Regulator Clears Phase II Trial of Tt-01488 Combo in Mantle Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2648173425","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648173425?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:04","pubTimestamp":1782903848,"startTime":"0","endTime":"0","summary":"TransThera says China regulator clears Phase II trial of TT-01488 combo in mantle cell lymphomaTransthera Sciences received China NMPA clearance on July 1, 2026 to start a Phase II trial of TT-01488 t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL6bFrgH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111653620","title":"Movement Alert｜TransThera Sciences-B Intraday Decline 8.18%, Buyback Plan Boost Fades as Post-Lockup Selling Pressure Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=1111653620","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111653620?lang=en_us&edition=fundamental","pubTime":"2026-06-30 11:00","pubTimestamp":1782788448,"startTime":"0","endTime":"0","summary":"On June 30, TransThera Sciences-B fell 8.18% in regular trading, trading at HK$11.75/share, with turnover of HK$206 million. The stock gave back most of the prior session's gains as the positive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105001263","title":"Movement Alert｜TransThera Sciences-B Rises 19.89% in Regular Trading, Company Announces Up to RMB 100 Million H-Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1105001263","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105001263?lang=en_us&edition=fundamental","pubTime":"2026-06-29 10:06","pubTimestamp":1782698781,"startTime":"0","endTime":"0","summary":"On June 29, TransThera Sciences-B rose 19.89% in regular trading, trading at HKD 10.85/share, with turnover of HKD 187 million.On the news front, the company announced on June 28 that its Board of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647342670","title":"Transthera Sciences Jumps Most in Nearly Four Months on Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2647342670","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647342670?lang=en_us&edition=fundamental","pubTime":"2026-06-29 10:05","pubTimestamp":1782698728,"startTime":"0","endTime":"0","summary":"BUZZ-TransThera Sciences jumps most in nearly four months on share buyback plan** Shares of TransThera Sciences  Inc2617.HKjump 21.3% to HK$11.04, on course for their biggest one-day pct gain since March 6** Stock hits the highest level since June 24, on track to snap five straight sessions of falls** China-based co says it intends to repurchase shares in the open market for up to 100 mln yuan  to demonstrate its confidence in its own business outlook and prospects** Co develops innovative small molecule therapies for oncology, inflammatory and cardiometabolic diseases** YTD, stock down 90.4%, Hang Seng Biotech Index.HSBIOdown 13.6%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nL1N43100Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187523767","title":"HK Movers | Hong Kong Biotech Sector Strengthened; TRANSTHERA Rose More Than 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187523767","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187523767?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:51","pubTimestamp":1782697878,"startTime":"0","endTime":"0","summary":"Hong Kong biotech sector strengthened;  $TRANSTHERA-B(02617)$  rose nearly 20%,  $HUA MEDICINE-B(02552)$  gained over 7%, and  $XTALPI(02228)$  and  $JOINN(06127)$  also advanced.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","02552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103412748","title":"TRANSTHERA-B Announces Market Buyback Plan Under General Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=1103412748","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103412748?lang=en_us&edition=fundamental","pubTime":"2026-06-28 21:00","pubTimestamp":1782651630,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (HKEX: 02617) has issued an announcement regarding its intention to repurchase shares on the open market.In accordance with the general mandate for H-share repurchases approved by the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188827955","title":"TransThera Sciences plans on-market buyback of up to RMB100.00 million under existing mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=1188827955","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188827955?lang=en_us&edition=fundamental","pubTime":"2026-06-28 18:23","pubTimestamp":1782642225,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing), Inc. (the “Company”) has announced its intention to repurchase H shares on the open market for an aggregate amount not exceeding RMB100.00 million, or the equivalent in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173650002","title":"Innovative Drug Firm's Market Value Plummets Over 200 Billion in a Year, Top Executives Draw Millions in Pay Despite Zero Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1173650002","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173650002?lang=en_us&edition=fundamental","pubTime":"2026-06-25 22:22","pubTimestamp":1782397327,"startTime":"0","endTime":"0","summary":"The stock price of an innovative drug company, once dubbed a \"meme stock\" with a market cap nearing 270 billion Hong Kong dollars, has now collapsed to less than 4 billion.On June 23rd, TRANSTHERA-B...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101880330","title":"TRANSTHERA-B Shares Extend Losses, Hitting New Low with Market Cap Below HK$4.5 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1101880330","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101880330?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:52","pubTimestamp":1782269547,"startTime":"0","endTime":"0","summary":"Shares of TRANSTHERA-B (02617) continued their decline, falling over 4% during the morning session to hit a new low of HK$10.51. This follows a steep drop of nearly 60% in the previous trading day....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","BK1161","BK4585","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100203407","title":"TRANSTHERA-B Shares Plunge Approximately 60% Amid Major Shareholder Lock-Up Expiry and Three Discounted Placements in Six Months","url":"https://stock-news.laohu8.com/highlight/detail?id=1100203407","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100203407?lang=en_us&edition=fundamental","pubTime":"2026-06-23 13:11","pubTimestamp":1782191461,"startTime":"0","endTime":"0","summary":"The lock-up period for TRANSTHERA-B (02617) entered its second stage of expiry on June 23, marking one year since its listing. According to the company's shareholder information as of December 31,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644098086","title":"TransThera Sets Up Strategy Committee to Tighten Governance and Guide Long-Term Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2644098086","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644098086?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:14","pubTimestamp":1781788486,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing). Inc. ( ($HK:2617) ) has issued an announcement. TransThera Sciences (Nanjing), Inc. has established a Strategy Commi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transthera-sets-up-strategy-committee-to-tighten-governance-and-guide-long-term-investments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transthera-sets-up-strategy-committee-to-tighten-governance-and-guide-long-term-investments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166997581","title":"TransThera Sciences: All AGM Resolutions Cleared; New INED Appointed, Supervisory Committee Dissolved","url":"https://stock-news.laohu8.com/highlight/detail?id=1166997581","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166997581?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:46","pubTimestamp":1781786774,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing), Inc. (TransThera) announced that shareholders approved every item on the agenda at the 18 June 2026 Annual General Meeting (AGM), endorsing both operational and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644083773","title":"Transthera Sciences files directors list with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2644083773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644083773?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:28","pubTimestamp":1781785733,"startTime":"0","endTime":"0","summary":"Transthera Sciences  filed an updated list of directors with the Hong Kong Stock Exchange on June 18, 2026.Board lineup: executive directors Dr. Frank Wu, Wu Di; non-executive director Jia Zhongxin; independent non-executive directors Chui Hoi Yam, Li Shu Pai, Feng Weibo.Committee roles: Frank Wu chairs the strategy committee; Li Shu Pai chairs the audit committee; Feng Weibo chairs the remuneration and appraisal committee.Nomination committee chaired by Chui Hoi Yam; Frank Wu, Feng Weibo serve as members.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 18","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL56c58L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1615","02617","BK0102","09898","BK0082","BK1095","BK0081","BK0010","BK1161","BK0215","600962"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144424771","title":"Appointment of Feng Weibo as Independent Non-Executive Director at TRANSTHERA-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1144424771","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144424771?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:28","pubTimestamp":1781785700,"startTime":"0","endTime":"0","summary":"Following the approval at the Annual General Meeting, Mr. Feng Weibo has been appointed as an Independent Non-Executive Director of the second-term board of directors at TRANSTHERA-B (ASX:...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644083731","title":"TransThera Sciences names Feng Weibo independent director, replacing Zheng Zhelan","url":"https://stock-news.laohu8.com/highlight/detail?id=2644083731","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644083731?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:24","pubTimestamp":1781785487,"startTime":"0","endTime":"0","summary":"Transthera Sciences  appointed Feng Weibo as an independent non-executive director, effective June 18, 2026, replacing Zheng Zhelan.Feng also took over as chair of the remuneration and appraisal committee.He joined the audit committee, joined the nomination committee.Zheng stepped down as remuneration and appraisal committee chair, exited the audit committee, exited the nomination committee at the AGM’s close.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL2P4Pwp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1095","BK1615","09898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101057331","title":"TRANSTHERA-B Appoints Sun Delong as Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=1101057331","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101057331?lang=en_us&edition=fundamental","pubTime":"2026-06-12 21:26","pubTimestamp":1781270775,"startTime":"0","endTime":"0","summary":"The board of directors of TRANSTHERA-B (02617) has announced the appointment of Mr. Sun Delong as the company's Chief Operating Officer, effective from June 12, 2026.In this role, Mr. Sun will be...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":140,"code":"91000000","status":"200"}]}}